GlassScriptPhysician profile
Michael Schenden
NPI 1831266485
$1,861.24
in general payments reported to CMS, 2019-2025
12 companies · $248 in 2025
The $248 reported for 2025 was more than what a typical provider received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $276 · 2020: $57.61 · 2021: $296 · 2022: $489 · 2023: $158 · 2024: $338 · 2025: $248.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $744.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $743.89 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Allergan, INC. | $436.26 | 2019-2022 | |
| Mentor Worldwide LLC | $376.78 | 2019-2025 | Mentor Memorygel Resterilizable Gel Sizer |
| Abbvie INC. | $237.81 | 2023-2025 | Botox |
| Sientra, INC. | $208.65 | 2021-2022 | |
| Galderma Laboratories, L.P. | $171.04 | 2019-2023 | |
| Polynovo North America LLC | $141.17 | 2024 | Novosorb Btm |
| Becton, Dickinson and Company | $96.01 | 2025 | Phasix Mesh |
| Integra Lifesciences Corporation | $73.14 | 2021-2024 | Integra, Surgimend, Integra Dermal Regeneration Template |
| Musculoskeletal Transplant Foundation INC. | $52.14 | 2024-2025 | |
| Medtronic, INC. | $26.28 | 2022 | |
| Urgo Medical North America, LLC | $24.67 | 2023 | Urgok2, Vashe Wound Solution 250 Ml (8.5 Fl Oz) Flip Top Cap |
| Motiva USA, LLC | $17.29 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Schenden listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.